en
Pharmaceuticals
Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
A C D E F G I J L M N O P R S T V X Z
TOBI*
(tobramycin solution for inhalation)
Respiratory Antibiotic
*TOBI is a registered trademark
TOBI* Podhaler*
(Tobramycin Inhalation Powder)
Respiratory Antibiotic
* TOBI and Podhaler are registered trademarks
Tasigna*
(nilotinib)
Protein-tyrosine Kinase Inhibitor
Important information for healthcare professionals (2013)
Important information for healthcare professionals (2011)
Important information for healthcare professionals (2010)
*Tasigna is a registered trademark
Tegretol*
(carbamazepine)
Anticonvulsant, Antimanic, For Symptomatic Relief Of Trigeminal Neuralgia
Important information for healthcare professionals (2008)
*Tegretol is a registered trademark
Transderm-Nitro*
(nitroglycerin)
Antianginal Agent
*Transderm-Nitro is a registered trademark
Transderm-V*
(scopolamine)
Anti-Motion Sickness Agent
*Transderm-V is a registered trademark
Trileptal*
(oxcarbazepine)
Antiepileptic
Important information for healthcare professionals (2005)
*Trileptal is a registered trademark
Research
Novartis is one of the industry’s biggest investors in research.
Gilenya* (Fingolimod)
This information is intended for Canadian healthcare professionals only
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Sandoz
Sandoz is one of the leaders in the development, manufacturing and distribution of generic pharmaceutical products.